Clincosm LogoSign in Get a demo

survival

Showing 1 - 25 of 66
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Long-term Survival and Quality of Life After Minimally Invasive

Not yet recruiting
  • Esophagus Cancer
  • +3 more
    • Ji'nan, Shandong, China
      Qilu Hospital of Shandong University
    Nov 19, 2023

    Peritoneal Dialysis Complication, Residual Kidney Function, Survival Trial (Single daily icodextrin exchange, Conventional PD

    Not yet recruiting
    • Peritoneal Dialysis Complication
    • +3 more
    • Single daily icodextrin exchange
    • Conventional PD group
    • (no location specified)
    Nov 5, 2023

    Blood Loss, Intensive Care, Anastomotic Leakage Trial in Alexandria (LAPAROSCOPIC RIGHT HEMICOLECTOMY procedure (intervention),

    Not yet recruiting
    • Blood Loss
    • +5 more
    • LAPAROSCOPIC RIGHT HEMICOLECTOMY procedure (intervention)
    • +3 more
    • Alexandria, Egypt
      The surgical department of Medical Research Institute Hospital,
    Sep 19, 2023

    Quality of Life and Survival of Radical Prostatectomy

    Not yet recruiting
    • Prostatic Neoplasms
    • +4 more
    • frailty
    • (no location specified)
    Jul 9, 2023

    Breast Cancer, Telerehabilitation, Exercise Trial in Gaziantep (Aerobic exercise)

    Recruiting
    • Breast Cancer
    • +3 more
    • Aerobic exercise
    • Gaziantep, Turkey
      Ramazan Cihad Yılmaz
    Jan 31, 2023

    Metabolic Syndrome and Long-term Survival Following Liver

    Recruiting
    • Survival
      • Assiut, Egypt
        Ahmed Mohammed Abu-Elfatth
      Oct 2, 2022

      Esophageal Cancer, Surgery, Neoadjuvant Treatment Trial in Zhengzhou (Neoadjuvant immunochemo)

      Recruiting
      • Esophageal Cancer
      • +3 more
      • Neoadjuvant immunochemotherapy
      • Zhengzhou, Henan, China
        Henan Cancer Hospital (The Affiliated Cancer Hospital of Zhengzh
      Oct 2, 2022

      Swedish Oesophago-Gastric Study

      Recruiting
      • Oesophageal Cancer
      • +7 more
      • Surgery
      • Stockholm, Sweden
        Karolinska Institutet
      Sep 15, 2022

      Breast Tumors, Treatment, Metastatic Breast Cancer Trial (surgical treatment 1, surgical treatment 2, Systemic therapy)

      Not yet recruiting
      • Breast Neoplasms
      • +3 more
      • surgical treatment 1
      • +2 more
      • (no location specified)
      Jul 17, 2022

      Effects of Antiviral Therapy on Patients With HBV-related HCC

      Completed
      • Hepatocellular Carcinoma
      • +2 more
      • Medication history
      • (no location specified)
      Jun 17, 2022

      Elderly Donor Liver in Liver Transplantation

      Completed
      • Liver Transplantation
      • +2 more
      • Age
      • (no location specified)
      Apr 27, 2022

      Aged, Tumors, Surgical Procedure, Operative Trial in China (Sevoflurane, Propofol)

      Active, not recruiting
      • Aged
      • +5 more
      • Beijing, Beijing, China
      • +14 more
      Apr 25, 2022

      Aged, Tumors, Surgical Procedure, Operative Trial in China (Sevoflurane, Propofol)

      Completed
      • Aged
      • +5 more
      • Beijing, Beijing, China
      • +16 more
      Mar 1, 2022

      Colorectal Cancer, Chemo Effect, Surgery Trial (Mitomycin, Lobaplatin)

      Not yet recruiting
      • Colorectal Cancer
      • +4 more
      • (no location specified)
      Feb 18, 2022

      Gastric Cancer, Chemo Effect, Surgery Trial in Wuhan (Paclitaxel, Lobaplatin)

      Recruiting
      • Gastric Cancer
      • +4 more
      • Wuhan, Hubei, China
        Wuhan Union Hospital
      Feb 18, 2022

      Completion Radical Cholecystectomy Determine Survival in

      Completed
      • Gall Bladder Carcinoma
      • Survival
      • Curative surgery
      • (no location specified)
      Nov 5, 2021

      Esophageal Squamous Cell Carcinoma, Chemoradiotherapy, Survival Trial in Nanjing, Shanghai (Paclitaxel plus carboplatin,

      Recruiting
      • Esophageal Squamous Cell Carcinoma
      • +2 more
      • Paclitaxel plus carboplatin
      • radiotherapy
      • Nanjing, Jiangsu, China
      • +2 more
      Oct 31, 2021

      Cardiac Surgery, Cardiopulmonary Bypass, Dexmedetomidine Trial in Beijing (Dexmedetomidine, Placebo)

      Active, not recruiting
      • Cardiac Surgery
      • +4 more
      • Beijing, Beijing, China
      • +1 more
      Sep 14, 2021

      Hospice, Survival, Alternative Medicine Trial in Changhua (Infrared Lamp and Acupressure)

      Completed
      • Hospice
      • +3 more
      • Infrared Lamp and Acupressure
      • Changhua, Taiwan
        Changhua Christian Hospital
      Aug 22, 2021

      Long-term Survivorship of Discharged Malignant Tumor Based on

      Recruiting
      • Neoplasms
      • +4 more
      • hospitalization
      • Shanghai, China
        Fudan University Shanghai Cancer Center
      Aug 2, 2021

      Anesthesia, Brain Cancer, Survival Trial (Propofol group, Sevoflurane group)

      Not yet recruiting
      • Anesthesia
      • +2 more
      • Propofol group
      • Sevoflurane group
      • (no location specified)
      Jul 22, 2021

      Survival, Postoperative Morbidity, Mortality Trial in St. Gallen (taTME, abdTME)

      Active, not recruiting
      • Survival
      • +3 more
      • taTME
      • abdTME
      • St. Gallen, Saint Gallen, Switzerland
        Department of surgery, Cantonal hospital of St. Gallen
      Jul 9, 2021

      Elderly Patients, Malnutrition, Hip Fractures Trial in Beijing, Tianjin (Nutritional intervention group, Control group)

      Recruiting
      • Elderly Patients
      • +5 more
      • Nutritional intervention group
      • Control group
      • Beijing, Beijing, China
      • +2 more
      Jul 10, 2021

      Effect of Sinovac on Survival in Intensive Care Unit

      Completed
      • Survival
      • Intensive Care Unit
        • Istanbul, Turkey
          Sisli Hamidiye Etfal Research and Training Hospital
        Jun 30, 2021

        Nasopharyngeal Carcinoma, Metastasis, Chemo Trial in Guangzhou (Triprilimab(JS001), Cisplatin, 5-Fluorouracil)

        Not yet recruiting
        • Nasopharyngeal Carcinoma
        • +4 more
        • Guangzhou, Guangdong, China
          Department of Radiation Oncology, Sun Yat-Sen University Cancer
        May 16, 2021